TRAF3IP2 and soft tissue sarcoma: The recent study by Leuci et al. demonstrated in vitro and in vivo the anti-tumor activity of CSPG4-CAR.CIKs in soft tissue sarcomas, including GIST cell lines, and reported that tumor elimination in vitro was dependent on the expression level of tumor cells.